Osteoporosis drugs on every 2026 Guam Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Guam cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$0.00/moS5820-035 |
|---|---|
| alendronategeneric Fosamax | Tier 125%QL 30/30d |
| risedronategeneric Actonel | Not covered |
| ibandronategeneric Boniva | Tier 325%QL 1/28d |
| Proliadenosumab | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Tier 425%QL 1/180d |
| Evenityromosozumab | Not covered |
| Forteoteriparatide | Not covered |
| teriparatidegeneric Forteo | Tier 5PA25%QL 2.48/28d |
| Tymlosabaloparatide | Tier 5PA25%QL 1.56/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.